Cargando…
Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes
OBJECTIVE—Bedtime administration of 5.0 mg of the β(2)-adrenergic agonist terbutaline prevents nocturnal hypoglycemia but causes morning hyperglycemia in type 1 diabetes. We tested the hypothesis that 2.5 mg terbutaline prevents nocturnal hypoglycemia without causing morning hyperglycemia. RESEARCH...
Autores principales: | Cooperberg, Benjamin A., Breckenridge, Suzanne M., Arbelaez, Ana Maria, Cryer, Philip E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584177/ https://www.ncbi.nlm.nih.gov/pubmed/18782903 http://dx.doi.org/10.2337/dc08-0520 |
Ejemplares similares
-
Duration of Nocturnal Hypoglycemia Before Seizures
por: Buckingham, Bruce, et al.
Publicado: (2008) -
Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial
por: Campbell, Matthew D, et al.
Publicado: (2015) -
Hypoglycemia Subtypes in Type 1 Diabetes: An Exploration of the Hypoglycemia Fear Survey-II
por: Maclean, Rory H., et al.
Publicado: (2022) -
Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies
por: Lin, Yu Kuei, et al.
Publicado: (2022) -
Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2017)